Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Aduhelm
Aduhelm
Scoop: Biogen will finally publish its PhIII results for Aduhelm
Endpoints
Wed, 03/16/22 - 10:22 am
Biogen
Aduhelm
Alzheimer's disease
Eisai hands off responsibility for Aduhelm to Biogen
Pharmaforum
Tue, 03/15/22 - 11:43 am
Eisai
Biogen
Aduhelm
Alzheimer's disease
Alzheimer's patient groups pressure U.S. to pay for Biogen drug
Reuters
Sun, 03/13/22 - 11:07 pm
Alzheimer's disease
Biogen
Aduhelm
patient groups
Biogen's Aduhelm still has blockbuster potential if everything breaks right: analyst
Fierce Pharma
Fri, 03/4/22 - 09:47 am
Biogen
Aduhelm
Alzheimer's disease
physicians
analysts
Biogen, struggling to sell Alzheimer's drug, begins layoffs to save money
BioPharma Dive
Thu, 03/3/22 - 12:12 pm
Biogen
layoffs
Aduhelm
Alzheimer's disease
3 more deaths among patients on Biogen's Aduhelm fuel safety concerns, though no link established: analyst
Fierce Pharma
Wed, 02/16/22 - 11:19 pm
Biogen
Aduhelm
Alzheimer's disease
patient deaths
Eli Lilly and Roche ask CMS not to be lumped in with Aduhelm’s restrictive judgment
Endpoints
Mon, 02/14/22 - 11:06 am
Eli Lilly
Roche
Biogen
Alzheimer's disease
Aduhelm
CMS
Eisai bites back against restricted coverage plan for Aduhelm
Pharmaforum
Thu, 02/10/22 - 10:16 am
Eisai
Biogen
Aduhelm
Alzheimer's disease
FDA
CMS
Backing Biogen, 75+ House Republicans call on CMS to abandon its decision to limit amyloid-targeted Alzheimer's drugs to trials
Endpoints
Wed, 02/9/22 - 10:53 pm
Biogen
Aduhelm
CMS
Alzheimer's disease
Biogen says U.S. FTC, SEC probing Alzheimer's disease drug
Reuters
Mon, 02/7/22 - 11:26 pm
Biogen
Aduhelm
FTC
SEC
Alzheimer's disease
After disastrous start to launch, Biogen still expects 'minimal' sales from Aduhelm this year
Fierce Pharma
Thu, 02/3/22 - 11:45 am
Biogen
earnings
Aduhelm
Alzheimer's disease
CMS' Biogen decision could spell problems for Lilly, Roche Alzheimer's drugs, half of surveyed neurologists say
Fierce Pharma
Tue, 02/1/22 - 10:50 am
CMS
Biogen
Aduhelm
Eli Lilly
Roche
Alzheimer's disease
Biogen promises increased diversity in Phase 4 Aduhelm trial
Biopharma Reporter
Tue, 02/1/22 - 10:41 am
Biogen
Aduhelm
clinical trials
clinical trial diversity
Two Biogen board members depart as company struggles to get Aduhelm off the ground
Fierce Pharma
Mon, 01/31/22 - 11:49 pm
Biogen
Aduhelm
Scott Gottlieb criticizes CMS in feud over Aduhelm coverage, calls out their lack of expertise
Endpoints
Thu, 01/27/22 - 11:41 pm
Biogen
Aduhelm
CMS
Scott Gottlieb
Under pressure, Biogen outlines ambitious diversity goals for Aduhelm study — but the Medicare fight is still on
Endpoints
Thu, 01/27/22 - 10:58 am
Biogen
Alzheimer's disease
clinical trials
clinical trial diversity
Aduhelm
A senior Biogen commercial exec exits Alzheimer's unit amid exodus as Aduhelm woes mount
Endpoints
Thu, 01/27/22 - 10:42 am
Biogen
Alzheimer's disease
Aduhelm
Confidence is high for Eli Lilly CEO Ricks in showdown with Biogen's Aduhelm
Fierce Biotech
Fri, 01/21/22 - 11:13 am
Eli Lilly
Biogen
Alzheimer's disease
Aduhelm
donanemab
clinical trials
David Ricks
Where Will Biogen Be in 5 Years?
Motley Fool
Sun, 01/16/22 - 03:56 am
Biogen
Aduhelm
zuranolone
BIIB115
lecanemab
Biogen compiles buyout target list as Aduhelm woe deepens: Stat
Fierce Pharma
Fri, 01/14/22 - 01:19 pm
Biogen
Aduhelm
M&A
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »